To evaluate Safety and Immunogenicity of a Booster Dose of Zoster Vaccine Compared with Zoster Vaccine Administered for the 1st Time to Elderly Individuals

Trial Profile

To evaluate Safety and Immunogenicity of a Booster Dose of Zoster Vaccine Compared with Zoster Vaccine Administered for the 1st Time to Elderly Individuals

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2016

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Herpes zoster; Varicella zoster virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 07 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top